| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 24,392 | 24,674 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 284 | 304 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -26,893 | 828 |
| Cash and cash equivalents at beginning of period | 45,777 | - |
| Cash and cash equivalents at end of period | 18,884 | - |
ORTHOPEDIATRICS CORP (KIDS)
ORTHOPEDIATRICS CORP (KIDS)